Literature DB >> 21765675

The 500 heart transplant.

M R Mehra1.   

Abstract

Year:  2000        PMID： 21765675      PMCID： PMC3117536     

Source DB:  PubMed          Journal:  Ochsner J        ISSN： 1524-5012


× No keyword cloud information.
  6 in total

1.  The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.

Authors:  M R Mehra; H O Ventura; R B Chambers; K Ramireddy; F W Smart; D D Stapleton
Journal:  J Heart Lung Transplant       Date:  1997-07       Impact factor: 10.247

Review 2.  The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift.

Authors:  M R Mehra; H O Ventura; D D Stapleton; F W Smart
Journal:  J Heart Lung Transplant       Date:  1995 Nov-Dec       Impact factor: 10.247

Review 3.  Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside.

Authors:  M R Mehra; H O Ventura; F W Smart; D D Stapleton
Journal:  J Heart Lung Transplant       Date:  1995 Nov-Dec       Impact factor: 10.247

4.  Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy.

Authors:  M R Mehra; H O Ventura; D D Stapleton; A K Karsan; F W Smart; S R Ramee; T J Collins
Journal:  Am Heart J       Date:  1997-06       Impact factor: 4.749

5.  Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy.

Authors:  M R Mehra; H O Ventura; S P Jain; K Ramireddy; A Ali; D D Stapleton; F W Smart; S R Ramee; T J Collins; C J White
Journal:  J Am Coll Cardiol       Date:  1997-05       Impact factor: 24.094

6.  Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.

Authors:  M R Mehra; H O Ventura; R Chambers; T J Collins; S R Ramee; M A Kates; F W Smart; D D Stapleton
Journal:  J Am Coll Cardiol       Date:  1995-11-15       Impact factor: 24.094
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.